Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children

• Toshihiro Yamaguchi,
• Masao Iwagami,
• Chieko Ishiguro,
• Souichirou Kitao,
• Masashi Tetsuhashi,
• Masato Izumi,
• Shingo Yoshihara,
• Hiroshi Kobatake,
• Yoshifumi Banzai,
• Natsumi Kinoshita,
• Toyotaka Iguchi,
• Akira Oka,
• Tomohiro Morio,
• Kiyohito Nakai,
• Shuichiro Hayashi,
• Ryo Takagi

Affiliations

Toshihiro Yamaguchi

Office of Counsellor for Vaccination, Health Service Division, Health Service Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan

Masao Iwagami

Department of Health Services Research, Institute of Medicine, University of Tsukuba, Ibaragi, Japan; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom

Chieko Ishiguro

Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan; Corresponding author. Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.

Souichirou Kitao

Pharmaceutical Safety Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan

Masashi Tetsuhashi

Pharmaceutical Safety Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan

Masato Izumi

Office of Counsellor for Vaccination, Health Service Division, Health Service Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan

Shingo Yoshihara

Office of Counsellor for Vaccination, Health Service Division, Health Service Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan

Hiroshi Kobatake

Office of Counsellor for Vaccination, Health Service Division, Health Service Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan

Yoshifumi Banzai

Office of Counsellor for Vaccination, Health Service Division, Health Service Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan

Natsumi Kinoshita

Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

Toyotaka Iguchi

Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan

Akira Oka

Saitama Children's Medical Center, Saitama, Japan

Tomohiro Morio

Department of Pediatrics, Tokyo Medical and Dental University Graduate School, Tokyo, Japan

Kiyohito Nakai

Pharmaceutical Safety Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan

Shuichiro Hayashi

Office of Counsellor for Vaccination, Health Service Division, Health Service Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan

Ryo Takagi

Office of Counsellor for Vaccination, Health Service Division, Health Service Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan; Corresponding author. Ministry of Health, Labour and Welfare, 1-2-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-8916, Japan.